Patent · US Active

Anti-PD-1/anti-HER2 natural antibody structural heterodimeric bispecific antibody and method of preparing same

US11753471B2 · kind B2 · utility

0Cited by
12References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateFeb 8, 2019
Grant dateSep 12, 2023
Priority date
Expiry dateJun 10, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are an anti-PD-1/anti-HER2 natural antibody structural heterodimeric bispecific antibody and a method of preparing the same. More particularly, provided are a highly stable heterodimeric anti-PD-1/anti-HER2 bispecific antibody having natural IgG characteristics without mismatch between a heavy chain and a light chain, and a method of preparing the same. The bispecific antibody may bind to two target molecules simultaneously and has excellent effects in treatment of a complex disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.